je.st
news
Tag: awardees
$650,000 Special Appropriations Awardees FY17-18
2017-10-11 19:42:04| PortlandOnline
$650,000 Special Appropriations Awardees FY17-18 PDF Document, 80kbCategory: Special Appropriations Awardees FY 2017-18
Tags: special
appropriations
awardees
special appropriations
$650,000 Special Appropriations Awardees FY17-18
2017-10-02 17:53:45| PortlandOnline
$650,000 Special Appropriations Awardess FY17-18 PDF Document, 15kbCategory: Special Appropriations Awardees FY 2017-18
Tags: special
appropriations
awardees
special appropriations
PUAH Special Appropriations Awardees FY17-18
2017-10-02 16:59:21| PortlandOnline
PUAH Special Appropriations Awardees FY17-18 PDF Document, 70kbCategory: Special Appropriations Awardees FY 2017-18
Tags: special
appropriations
awardees
special appropriations
A Brief History of Naito Awardees
2016-12-01 23:53:18| PortlandOnline
Past recipients of the Naito Community Trees Award
Merck Congratulates Awardees of 2015 Nobel Prize in Physiology or Medicine for Discovery Leading to River Blindness Treatment
2015-10-05 23:15:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Co-recipient Dr. William C. Campbell Conducted his Nobel Prize-winning Work at Merck Research Laboratories KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, proudly congratulates William C. Campbell, a retired scientist from Merck Research Laboratories, who was jointly named the 2015 Nobel Prize winner in Physiology or Medicine with Satoshi Omura for the discovery of avermectin, which led to Mercks development of Mectizan (ivermectin), a treatment for river blindness (also known as onchocerciasis) in Africa, Latin America and Yemen. Language: English Contact: MerckMedia:Lainie Keller, 908-236-5036orClaire Gillespie, 267-305-0932orInvestors:Terri Loxam, 908-740-1986orJustin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: to
treatment
leading
river